XBiotech Inc.

NASDAQ: XBIT · Real-Time Price · USD
3.20
-0.04 (-1.23%)
At close: Aug 15, 2025, 3:59 PM
3.15
-1.56%
After-hours: Aug 15, 2025, 04:10 PM EDT

XBiotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
172.68M 200.02M 157.31M 236.98M
Short-Term Investments
n/a n/a 60.17M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a -1.09M
Receivables
858K 935K 1.76M 8.95M
Inventory
n/a n/a n/a -8.95M
Other Current Assets
1.03M 760K 601K n/a
Total Current Assets
174.57M 201.72M 219.84M 246.87M
Property-Plant & Equipment
24.53M 24.9M 26.26M 28.31M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
24.53M 24.9M 26.26M 28.31M
Total Assets
199.09M 226.62M 246.1M 275.18M
Account Payables
2.22M 2.52M 2.41M 2.07M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
10.25M n/a n/a n/a
Other Current Liabilities
611K 562K 1.17M 904K
Total Current Liabilities
15.11M 6.1M 4.07M 3.45M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
1.72M 1.67M 1.58M 1.47M
Total Long-Term Liabilities
1.72M 1.67M 1.64M 2.34M
Total Liabilities
16.82M 7.77M 5.7M 5.79M
Total Debt
10.25M n/a n/a n/a
Common Stock
273.11M 271.15M 267.32M 262.26M
Retained Earnings
-90.84M -52.31M -27.75M 5.15M
Comprehensive Income
n/a 0.00 826K 1.97M
Shareholders Equity
182.27M 218.85M 240.4M 269.38M
Total Investments
n/a n/a 60.17M n/a